← FDA DRUG APPROVALS

FDA ANDA · ANDA203034

DONEPEZIL

donepezil hydrochloride

Sponsor: HETERO LABS LTD V

APPLICATION
ANDA203034
TYPE
ANDA
ORIGINAL APPROVAL
2015-01-30
LATEST ACTION
2025-04-02
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

DONEPEZIL HYDROCHLORIDEPrescription
DONEPEZIL HYDROCHLORIDE 10MG · TABLET · ORAL
DONEPEZIL HYDROCHLORIDEPrescription
DONEPEZIL HYDROCHLORIDE 5MG · TABLET · ORAL

Approval history

2025-04-02Labeling · Supplement 10 · standardAP
2016-10-04Labeling · Supplement 1 · standardAP
2015-01-30UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →